$19.45
0.593.13%
Last update: Nov 3, 5:36 PM
Denali Therapeutics Inc (DNLI) Stock Price, Quote, News & History
DNLINASDAQ
Denali Therapeutics (NASDAQ:DNLI) reported third-quarter financial results on Tuesday. The transcript from the company’s third-quarter earnings call has been...
You can purchase shares of Denali Therapeutics (NASDAQ:DNLI) through any online brokerage.
Other companies in Denali Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Denali Therapeutics has a consensus price target of $35.16.
The stock price for Denali Therapeutics (NASDAQ: DNLI) is $20.7 last updated November 3, 2026 at 5:36 PM EST.
There are no upcoming dividends for Denali Therapeutics.
Denali Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Denali Therapeutics.
Denali Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegenerative diseases. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant...
